Labomar — Investor Relations & Filings
Labomar is a Contract Development and Manufacturing Organization (CDMO) that specializes in creating and producing food supplements, medical devices, foods for special medical purposes (FSMPs), and dermo-cosmetic products. The company operates as a full-service, one-stop-shop partner, offering customized development of bespoke products and ready-to-market formulations. Labomar leverages patented and advanced technologies with a strong emphasis on scientific research and innovation to manufacture high-quality products. Its services cover the entire product lifecycle, from formulation and the production of plant extracts to manufacturing and regulatory support for its clients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Comunicato Procedura congiunta e revoca | 2023-09-06 | Italian | |
| Comunicato ex art. 41, comma 2, lett. c) RE | 2023-08-31 | Italian | |
| Comunicato Risultati Definitivi Sell-Out | 2023-08-29 | Italian | |
| Comunicato Risultati Provvisori Sell-Out | 2023-08-28 | Italian | |
| Comunicato adesioni Sell-Out terza settimana | 2023-08-25 | Italian | |
| Comunicato Adesioni Sell Out Seconda Settimana | 2023-08-18 | Italian |
Browse filings by year
3 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CAPRICOR THERAPEUTICS, INC.
A clinical-stage biotech developing cell and exosome-based …
|
CAPR | US | Manufacturing |
|
Cardiogeni Plc
A clinical-stage biotech developing regenerative medicines …
|
— | GB | Manufacturing |
|
Cardiol Therapeutics Inc.
Clinical-stage company developing anti-inflammatory and ant…
|
CRDL | CA | Manufacturing |
|
CAREGEN CO.,LTD.
Develops biomimetic peptides and growth factors for aesthet…
|
214370 | KR | Manufacturing |
|
Caribou Biosciences, Inc.
Clinical-stage biopharma developing genome-edited allogenei…
|
CRBU | US | Manufacturing |
|
Carisma Therapeutics Inc.
A clinical-stage biotech developing engineered macrophage-b…
|
CARM | US | Manufacturing |
|
Carna Biosciences, Inc.
Clinical-stage biopharma developing small molecule kinase i…
|
4572 | JP | Manufacturing |
|
CARsgen Therapeutics Holdings Limited
Clinical-stage biopharma focused on developing innovative C…
|
2171 | HK | Manufacturing |
|
Cartesian Therapeutics, Inc.
A clinical-stage company developing mRNA-engineered cell th…
|
RNAC | US | Manufacturing |
|
CASI Pharmaceuticals, Inc.
Biopharmaceutical firm developing therapeutics for organ tr…
|
CASI | US | Manufacturing |
Labomar via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/4144/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=4144 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=4144 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=4144 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 4144}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Labomar (id: 4144)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.